Yu Feng
- Molecular Medicine top 5%
- Biochemistry top 5%
- Cancer Research top 10%
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 9
- Immunology top 10%
- Gastroenterology top 5%
-
- RNA modifications and cancer 13
- Circular RNAs in diseases 8
- Epigenetics and DNA Methylation 6
- RNA and protein synthesis mechanisms 4
-
- Gastric Cancer Management and Outcomes 5
-
- Colorectal Cancer Treatments and Studies 5
- Co-authors
- Michael ForgacXiliang ChenZhiyong ZhuXiaomin YangXiang ZhouQi LiuWeiting XuWei Zhang
- Journals
- Science (1 paper)Journal of Biological Chemistry (3 papers)The Journal of Experimental Medicine (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yu Feng
119 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 147
- Molecular Medicine 155
- Biochemistry 145
- Cancer Research 298
- Immunology 347
- Gastroenterology 90
Countries citing papers authored by Yu Feng
This map shows the geographic impact of Yu Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Feng more than expected).
Fields of papers citing papers by Yu Feng
This network shows the impact of papers produced by Yu Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Feng. The network helps show where Yu Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 26 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 16 | |
| 12 | 2021 | 14 | |
| 13 | MiR-34a Inhibits Cell Proliferation and Induces Apoptosis in Human Nasopharyngeal Carcinoma by Targeting lncRNA MCM3AP-AS1 | 2020 | 1 |
| 14 | 2018 | 79 | |
| 15 | Expression of Tlrs in decidual tissue of patients with unexplained recurrent spontaneous abortion | 2017 | 1 |
| 16 | 2017 | 49 | |
| 17 | 2016 | 8 | |
| 18 | 2016 | 18 | |
| 19 | 2014 | 131 | |
| 20 | Cloning of Human Lysozyme cDNA and Its in vivo Expression in Mouse | 2004 | 1 |
About Yu Feng
Yu Feng is a scholar working on Cancer Research, Physiology and Molecular Biology, having authored 127 papers that have together received 2.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (8 papers), Epigenetics and DNA Methylation (6 papers), Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and RNA and protein synthesis mechanisms (4 papers). The work is most often cited by research in Molecular Medicine (155 citations), Biochemistry (145 citations) and Cancer Research (298 citations). Yu Feng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Michael Forgac, Xiliang Chen, Zhiyong Zhu, Xiaomin Yang, Xiang Zhou, Qi Liu, Weiting Xu, Wei Zhang, Jianchang Chen and Xiang Zhou. Their work appears in journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.